Birchview Capital as of June 30, 2020
Portfolio Holdings for Birchview Capital
Birchview Capital holds 51 positions in its portfolio as reported in the June 2020 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Bristol Myers Squibb (BMY) | 28.2 | $47M | 792k | 58.80 | |
Accelr8 Technology | 20.1 | $33M | 2.2M | 15.16 | |
Aspira Womens Health | 7.7 | $13M | 3.3M | 3.84 | |
Quidel Corporation | 6.9 | $11M | 51k | 223.74 | |
Neurocrine Biosciences (NBIX) | 5.8 | $9.5M | 78k | 122.00 | |
ACADIA Pharmaceuticals (ACAD) | 2.7 | $4.5M | 93k | 48.47 | |
Bluebird Bio (BLUE) | 2.2 | $3.7M | 60k | 61.03 | |
Karyopharm Therapeutics (KPTI) | 1.9 | $3.2M | 168k | 18.94 | |
Biogen Idec (BIIB) | 1.8 | $2.9M | 11k | 267.55 | |
Bmy Cvr Rts 03/31/21 Right | 1.5 | $2.5M | 707k | 3.58 | |
Oxford Immunotec Global | 1.3 | $2.2M | 170k | 13.00 | |
United Therapeutics Corporation (UTHR) | 1.3 | $2.2M | 18k | 121.00 | |
Soleno Therapeutics | 1.1 | $1.8M | 827k | 2.22 | |
Masimo Corporation (MASI) | 1.1 | $1.8M | 8.0k | 228.00 | |
Amarin Corp Spons Adr New (AMRN) | 1.1 | $1.8M | 260k | 6.92 | |
Acceleron Pharma | 1.1 | $1.8M | 19k | 95.28 | |
Chemocentryx | 1.0 | $1.7M | 30k | 57.53 | |
Contrafect | 1.0 | $1.6M | 256k | 6.39 | |
Arena Pharmaceuticals | 0.8 | $1.4M | 22k | 62.95 | |
Albireo Pharma | 0.8 | $1.3M | 48k | 26.50 | |
Epizyme | 0.7 | $1.1M | 70k | 16.06 | |
Equitrans Midstream Corp (ETRN) | 0.7 | $1.1M | 133k | 8.31 | |
G1 Therapeutics (GTHX) | 0.6 | $970k | 40k | 24.25 | |
Myokardia | 0.6 | $966k | 10k | 96.60 | |
Harrow Health (HROW) | 0.6 | $938k | 180k | 5.21 | |
Vanda Pharmaceuticals (VNDA) | 0.6 | $915k | 80k | 11.44 | |
ImmunoGen | 0.5 | $874k | 190k | 4.60 | |
Odonate Therapeutics Ord | 0.5 | $847k | 20k | 42.35 | |
Corcept Therapeutics Incorporated (CORT) | 0.5 | $841k | 50k | 16.82 | |
Gilead Sciences (GILD) | 0.5 | $769k | 10k | 76.90 | |
Biohaven Pharmaceutical Holding | 0.4 | $731k | 10k | 73.10 | |
Continental Resources | 0.4 | $677k | 39k | 17.54 | |
Amicus Therapeutics (FOLD) | 0.3 | $573k | 38k | 15.08 | |
Translate Bio | 0.3 | $538k | 30k | 17.93 | |
Arvinas Ord (ARVN) | 0.3 | $503k | 15k | 33.53 | |
Inari Medical Ord (NARI) | 0.3 | $484k | 10k | 48.40 | |
Stoke Therapeutics (STOK) | 0.3 | $477k | 20k | 23.85 | |
Intercept Pharmaceuticals In | 0.2 | $398k | 8.3k | 47.95 | |
Xencor (XNCR) | 0.2 | $398k | 12k | 32.36 | |
Progyny (PGNY) | 0.2 | $387k | 15k | 25.80 | |
Voyager Therapeutics (VYGR) | 0.2 | $379k | 30k | 12.63 | |
Pioneer Natural Resources (PXD) | 0.2 | $371k | 3.8k | 97.63 | |
Kalvista Pharmaceuticals (KALV) | 0.2 | $363k | 30k | 12.10 | |
Encana Corporation (OVV) | 0.2 | $328k | 34k | 9.55 | |
Inflarx Nv (IFRX) | 0.2 | $321k | 70k | 4.59 | |
Tg Therapeutics (TGTX) | 0.2 | $292k | 15k | 19.47 | |
Workhorse Group Inc ordinary shares (WKHS) | 0.2 | $261k | 15k | 17.40 | |
Apellis Pharmaceuticals (APLS) | 0.2 | $261k | 8.0k | 32.62 | |
Dicerna Pharmaceuticals | 0.2 | $254k | 10k | 25.40 | |
Yield10 Bioscience | 0.1 | $118k | 19k | 6.23 | |
BioCryst Pharmaceuticals (BCRX) | 0.1 | $95k | 20k | 4.75 |